跳至主要内容
临床试验/IRCT20190604043813N4
IRCT20190604043813N4尚未招募3 期

Evaluating the effect of ursodeoxycholic acid in reducing hospitalization for intensive phototherapy in neonates with indirect hyperbilirubinemia referred to outpatient clinics in comparison with the control group

Shiraz University of Medical Sciences0 个研究点目标入组 148 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 days 至 15 days(—)
性别
All

入选标准

  • Exclusive breastfeeding,
  • Age above 1 day
  • Neonate born with gestational age 35 weeks or more
  • Total bilirubin between 3 mg / dL less than the level required for intensive phototherapy treatment in the hospital and the level required for hospitalization
  • Direct bilirubin levels below 2 mg / dL.
  • Parent consent
  • Infants whose parents agree not to use herbal or traditional medicines during the study period.

排除标准

  • Rh incompatibility
  • Uunderlying disease such as heart and liver disease
  • Infection and septicemia
  • Neonate of diabetic mother

研究者

相似试验